Matthew D. Ringel

The Ohio State University Wexner Medical Center

Papers

Total Citations

H-Index

About

Matthew D. Ringel is a leading endocrinologist and cancer researcher whose work has fundamentally advanced our understanding of thyroid cancer biology and treatment. His research primarily focuses on the molecular mechanisms driving thyroid cancer progression, metastasis, and resistance to therapy, with particular emphasis on the role of the BRAF mutation and the MAP kinase signaling pathway. Dr. Ringel has made seminal contributions by identifying key genetic and epigenetic alterations that distinguish aggressive thyroid cancers from indolent ones, and by developing novel therapeutic strategies targeting these pathways. His highly cited studies have shaped clinical guidelines for managing thyroid nodules and cancer, influencing how clinicians stratify risk and select treatments. With over 20,000 citations, his work is among the most influential in the field. Notably, Dr. Ringel has served as President of the American Thyroid Association and has received numerous awards for his research, including the prestigious Paul Starr Award. His recent innovative work on adrenal near-infrared autofluorescence demonstrates his continued commitment to advancing surgical and diagnostic techniques, further solidifying his reputation as a transformative figure in endocrine oncology.